Tacrolimus (Tacrolimus)



Indications and Reactions:

Role Indications Reactions
Primary
Immunosuppression 31.6%
Product Used For Unknown Indication 15.8%
Immunosuppressant Drug Therapy 13.2%
Liver Transplant 10.5%
Prophylaxis 5.3%
Renal Transplant 5.3%
Stem Cell Transplant 5.3%
Urinary Tract Infection 5.3%
Fungal Infection 2.6%
Herpes Simplex Hepatitis 2.6%
Latent Tuberculosis 2.6%
Drug Level Increased 20.0%
Immunosuppressant Drug Level Increased 6.7%
Lung Infection Pseudomonal 6.7%
Post Transplant Distal Limb Syndrome 6.7%
Renal Failure Chronic 6.7%
Renal Tubular Necrosis 6.7%
Supraventricular Tachycardia 6.7%
Thrombotic Microangiopathy 6.7%
Transaminases Increased 6.7%
Urinary Tract Infection 6.7%
Viraemia 6.7%
Vomiting 6.7%
Weight Increased 6.7%
Secondary
Prophylaxis Against Transplant Rejection 20.4%
Renal Transplant 18.0%
Immunosuppression 13.6%
Immunosuppressant Drug Therapy 13.2%
Ill-defined Disorder 9.2%
Burkitt's Lymphoma 4.0%
Drug Use For Unknown Indication 3.2%
Hepatitis C 2.8%
Lung Transplant 2.0%
Prophylaxis 2.0%
Graft Versus Host Disease In Skin 1.6%
Liver Transplant 1.6%
Anti-infective Therapy 1.2%
Graft Versus Host Disease 1.2%
Heart And Lung Transplant 1.2%
Respiratory Syncytial Virus Infection 1.2%
Transplant Rejection 1.2%
Convulsion Prophylaxis 0.8%
Gastrooesophageal Reflux Disease 0.8%
Nephrotic Syndrome 0.8%
Renal Failure Acute 8.9%
Vomiting 8.9%
Weight Decreased 8.9%
Renal Failure 6.7%
Transplant Rejection 6.7%
Progressive Multifocal Leukoencephalopathy 4.4%
Proteinuria 4.4%
Renal Failure Chronic 4.4%
Renal Impairment 4.4%
Renal Tubular Necrosis 4.4%
Respiratory Syncytial Virus Infection 4.4%
Rhinorrhoea 4.4%
T-cell Lymphoma 4.4%
Thrombotic Microangiopathy 4.4%
Ventricular Fibrillation 4.4%
Walking Aid User 4.4%
White Blood Cell Count Decreased 4.4%
Breast Cancer 2.2%
Clear Cell Carcinoma Of The Kidney 2.2%
Cutaneous Leishmaniasis 2.2%
Concomitant
Prophylaxis Against Transplant Rejection 34.3%
Renal Transplant 12.4%
Renal And Pancreas Transplant 7.6%
Hepatitis C 4.8%
Anti-infective Therapy 3.8%
Lung Infection 3.8%
Acute Graft Versus Host Disease 2.9%
Chronic Myeloid Leukaemia 2.9%
Cytomegalovirus Infection 2.9%
Ill-defined Disorder 2.9%
Immunosuppression 2.9%
Liver Abscess 2.9%
Transplant Rejection 2.9%
Acute Myeloid Leukaemia 1.9%
Arthritis Bacterial 1.9%
Aspergillosis 1.9%
Bronchopulmonary Aspergillosis 1.9%
Cryoglobulinaemia 1.9%
Drug Use For Unknown Indication 1.9%
Graft Versus Host Disease 1.9%
Hyponatraemia 8.3%
Post Procedural Complication 8.3%
Venous Thrombosis 8.3%
Kidney Transplant Rejection 6.3%
Pancreas Transplant Rejection 6.3%
Refusal Of Treatment By Patient 6.3%
Renal Failure Acute 6.3%
Hyperkalaemia 4.2%
Liver Function Test Abnormal 4.2%
Nephropathy Toxic 4.2%
Off Label Use 4.2%
Post Herpetic Neuralgia 4.2%
Pulmonary Tuberculosis 4.2%
Rectal Haemorrhage 4.2%
Sepsis 4.2%
Tachypnoea 4.2%
Transplant Rejection 4.2%
Vomiting 4.2%
Chorioretinopathy 2.1%
Drug Ineffective For Unapproved Indication 2.1%